A Pilot Study of Pulmozyme (rhDNase) in Patients With Head and Neck Cancers Treated With Radiation and Chemotherapy

Trial Profile

A Pilot Study of Pulmozyme (rhDNase) in Patients With Head and Neck Cancers Treated With Radiation and Chemotherapy

Active, no longer recruiting
Phase of Trial: Phase 0

Latest Information Update: 05 Dec 2016

At a glance

  • Drugs Dornase alfa (Primary)
  • Indications Head and neck cancer; Salivary gland disorders; Squamous cell cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 18 May 2011 Planned End Date changed from 1 Oct 2014 to 1 Dec 2016 as reported by ClinicalTrials.gov.
    • 18 May 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 05 May 2008 The actual start date for this study was Feb 2008 according to the clincialtrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top